Gangliosides as apoptotic signals in ER stress response

Cell Death and Differentiation

Volumn 13, Issue 3, 2006, Pages 404-414

  d'Azzo, Alessandra ^a   Tessitore, A ^b   Sano, R ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b Telethon Institute of Genetics and Medicine (TIGEM)   (United States)

Author keywords

Apoptosis; Calcium; ER stress; Gangliosides; Glycosphingolipids

Indexed keywords

CALCIUM; GANGLIOSIDE; GLYCOSPHINGOLIPID; MEMBRANE PROTEIN;

APOPTOSIS; CALCIUM HOMEOSTASIS; CALCIUM SIGNALING; CALCIUM TRANSPORT; CELL DEATH; CELL MEMBRANE; CHEMICAL COMPOSITION; DEGENERATIVE DISEASE; DISEASE ASSOCIATION; DOWNSTREAM PROCESSING; ENDOPLASMIC RETICULUM; HUMAN; LIPID ANALYSIS; LIPID DEGRADATION; LIPID METABOLISM; LIPID STORAGE; MEMBRANE STRUCTURE; MITOCHONDRIAL MEMBRANE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; STRESS; SYSTEMATIC REVIEW;

ANIMALS; APOPTOSIS; DISEASE MODELS, ANIMAL; ENDOPLASMIC RETICULUM; GANGLIOSIDES; HUMANS; MITOCHONDRIA; SIGNAL TRANSDUCTION; SPHINGOLIPIDOSES;

EID: 33645147348     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/sj.cdd.4401834     Document Type: Review

References (97)

1. Huwiler A, Kolter T, Pfeilschifter J and Sandhoff K (2000) Physiology and pathophysiology of sphingolipid metabolism and signaling. Biochim. Biophys. Acta 1485: 63-99
2. Tettamanti G (2004) Ganglioside/glycosphingolipid turnover: New concepts. Glycoconjugate J. 20: 301-317
3. Heffer-Lauc M, Lauc G, Nimrichter L, Fromholt SE and Schnaar RL (2005) Membrane redistribution of gangliosides and glycosylphosphatidylinositol-anchored proteins in brain tissue sections under conditions of lipid raft isolation. Biochim. Biophys. Acta 1686: 200-208
4. Ledeen RW and Wu G (2002) Ganglioside function in calcium homeostasis and signaling. Neurochem. Res. 27: 637-647
5. Malisan F and Testi R (2002) GD3 ganglioside and apoptosis. Biochim. Biophys. Acta 1585: 179-187
6. Miljan EA and Bremer EG (2002) Regulation of growth factor receptors by gangliosides. Sci. STKE 2002: RE15
7. Tessitore A, del PMM, Sano R, Ma Y, Mann L, Ingrassia A, Laywell ED, Steindler DA, Hendershot LM and d'Azzo A (2004) GM1-ganglioside-mediated activation of the unfolded protein response causes neuronal death in a neurodegenerative gangliosidosis. Mol. Cell 15: 753-766
8. Berridge MJ, Bootman MD and Roderick HL (2003) Calcium signalling: dynamics, homeostasis and remodelling. Nat. Rev. Mol. Cell. Biol. 4: 517-529
9. Kolter T, Proia RL and Sandhoff K (2002) Combinatorial ganglioside biosynthesis. J. Biol. Chem. 277: 25859-25862
10. Yu RK, Bieberich E, Xia T and Zeng G (2004) Regulation of ganglioside biosynthesis in the nervous system. J. Lipid Res. 45: 783-793
11. Kolter T and Sandhoff K (2005) Principles of lysosomal membrane digestion: Stimulation of sphingolipid degradation by sphingolipid activator proteins and anionic lysosomal lipids. Annu. Rev. Cell. Dev. Biol. 21: 81-103
12. Tettamanti G, Bassi R, Viani P and Riboni L (2003) Salvage pathways in glycosphingolipid metabolism. Biochimie 85: 423-437
13. Scriver C, Beaudet A, Sly W and Valle D (eds) (2001) The Metabolic & Molecular Bases of Inherited Disease (New York: McGraw-Hill)
14. D'Azzo A (2003) Gene transfer strategies for correction of lysosomal storage disorders. Acta Haematol. 110: 71-85
15. Futerman AH and van Meer G (2004) The cell biology of lysosomal storage disorders. Nat. Rev. Mol. Cell. Biol. 5: 554-565
16. Ginzburg L, Kacher Y and Futerman AH (2004) The pathogenesis of glycosphingolipid storage disorders. Semin. Cell Dev. Biol. 15: 417-431
17. Walkley SU, Zervas M and Wiseman S (2000) Gangliosides as modulators of dendritogenesis in normal and storage disease-affected pyramidal neurons. Cereb. Cortex 10: 1028-1037
18. Walkley SU (1998) Cellular pathology of lysosomal storage disorders. Brain Pathol. 8: 175-193
19. Jolly RD and Walkley SU (1997) Lysosomal storage diseases of animals: An essay in comparative pathology. Vet. Pathol. 34: 527-548
20. Jeyakumar M, Dwek RA, Butters TD and Platt FM (2005) Storage solutions: treating lysosomal disorders of the brain. Nat. Rev. Neurosci. 6: 713-725
21. Kaye EM, Alroy J, Raghavan SS, Schwarting GA, Adelman LS, Runge V, Gelblum D, Thalhammer JG and Zuniga G (1992) Dysmyelinogenesis in animal model of GM1 gangliosidosis. Pediatr. Neurol. 8: 255-261
22. Wenger DA (2000) Murine, canine and non-human primate models of Krabbe disease. Mol. Med. Today 6: 449-451
23. Zaka M and Wenger DA (2004) Psychosine-induced apoptosis in a mouse oligodendrocyte progenitor cell line is mediated by caspase activation. Neurosci. Lett. 358: 205-209
24. German DC, Liang CL, Song T, Yazdani U, Xie C and Dietschy JM (2002) Neurodegeneration in the Niemann-Pick C mouse: Glial involvement. Neuroscience 109: 437-450
25. Raivich G, Bohatschek M, Kloss C, Wemer A, Jones L and Kreutzberg G (1999) Neuroglial activation repertoire in the injured brain: Graded response, molecular mechanisms and cues to physiological function. Brain Res. Rev. 30: 77-105
26. Wada R, Tifft CJ and Proia RL (2000) Microglial activation precedes acute neurodegeneration in Sandhoff disease and is suppressed by bone marrow transplantation. Proc. Natl. Acad. Sci. USA 97: 10954-10959
27. Suzuki K (2003) Globoid cell leukodystrophy (Krabbe's disease): Update. J. Child. Neurol. 18: 595-603
28. Jeyakumar M, Thomas R, Elliot-Smith E, Smith DA, van der Spoel AC, d'Azzo A, Perry VH, Butters TD, Dwek RA and Platt FM (2003) Central nervous system inflammation is a hallmark of pathogenesis in mouse models of GM1 and GM2 gangliosidosis. Brain 126: 974-987
29. Sano R, Tessitore A, Ingrassia A and d'Azzo A (2005) Chemokine-induced recruitment of genetically modified bone marrow cells into the CNS of GM1-gangliosidosis mice corrects neuronal pathology. Blood 106: 2259-2268
30. M2 Gangliosidoses In The Metabolic & Molecular Bases of Inherited Disease, Scriver C, Beaudet A, Sly W, Valle D (eds) (New York: McGraw-Hill Publishing) pp 3827-3876
31. M1 gangliosidosis and Morquio B disease In The Metabolic and Molecular Bases of Inherited Disease, Scriver C, Beaudet A, Sly W, Valle D (eds) (New York: McGraw-Hill Publishing Co.) pp 3775-3809
32. Georgiou T, Drousiotou A, Campos Y, Caciotti A, Sztriha L, Gururaj A, Ozand P, Zammarchi E, Morrone A and D'Azzo A (2004) Four novel mutations in patients from the Middle East with the infantile form of GM1-gangliosidosis. Hum. Mutat. 24: 352
33. van der Voom JP, Kamphorst W, van der Knaap MS and Powers JM (2004) The leukoencephalopathy of infantile GM1 gangliosidosis: Oligodendrocytic loss and axonal dysfunction. Acta Neuropathol. (Berlin) 107: 539-545
34. Walkley SU (2004) Secondary accumulation of gangliosides in lysosomal storage disorders. Semin. Cell Dev. Biol. 15: 433-444
35. Ikonen E and Holtta-Vuori M (2004) Cellular pathology of Niemann-Pick type C disease. Semin. Cell Dev. Biol. 15: 445-454
36. Russell C, Hendson G, Jevon G, Matlock T, Yu J, Aklujkar M, Ng KY and Clarke LA (1998) Murine MPS I: Insights into the pathogenesis of Hurler syndrome. Clin. Genet. 53: 349-361
37. Jones MZ, Alroy J, Rutledge JC, Taylor JW, Alvord Jr EC, Toone J, Applegarth D, Hopwood JJ, Skutelsky E, Ianelli C, Thorley-Lawson D, Mitchell-Herpolsheimer C, Arias A, Sharp P, Evans W, Sillence D and Cavanagh KT (1997) Human mucopolysaccharidosis IIID: Clinical, biochemical, morphological and immunohistochemical characteristics. J. Neuropathol. Exp. Neurol. 56: 1158-1167
38. Ziegler-Heitbrock HW, Kafferlein E, Haas JG, Meyer N, Strobel M, Weber C and Flieger D (1992) Gangliosides suppress tumor necrosis factor production in human monocytes. J. Immunol. 148: 1753-1758
39. Tsuboi N, Utsunomiya Y, Kawamura T, Kikuchi T, Hosoya T, Ohno T and Yamada H (2003) Shedding of growth-suppressive gangliosides from glomerular mesangial cells undergoing apoptosis. Kidney Int. 63: 936-946
40. Andersson LM, Fredman P, Lekman A, Rosengren L and Gisslen M (1998) Increased cerebrospinal fluid ganglioside GD3 concentrations as a marker of microglial activation in HIV type 1 infection. AIDS Res. Hum. Retroviruses 14: 1065-1069
41. Trbojevic-Cepe M, Kracun I, Jusic A and Pavlicek I (1991) Gangliosides of human cerebrospinal fluid in various neurologic diseases. J. Neurol. Sci. 105: 192-199
42. Kawai K, Kuroda S, Watarai S, Takahashi H and Ikuta F (1994) Occurrence of GD3 ganglioside in reactive astrocytes - an immunocytochemical study in the rat brain. Neurosci. Lett. 174: 225-227
43. Simon BM, Malisan F, Testi R, Nicotera P and Leist M (2002) Disialoganglioside GD3 is released by microglia and induces oligodendrocyte apoptosis. Cell Death Differ. 9: 758-767
44. Ohtani Y, Tamai Y, Ohnuki Y and Miura S (1996) Ganglioside alterations in the central and peripheral nervous systems of patients with Creutzfeldt-Jakob disease. Neurodegeneration 5: 331-338
45. Yu RK, Ledeen RW and Eng LF (1974) Ganglioside abnormalities in multiple sclerosis. J. Neurochem. 23: 169-174
46. Bektas M and Spiegel S (2004) Glycosphingolipids and cell death. Glycoconjugate J. 20: 39-47
47. 2+-ATPase in a mouse model of Sandhoff disease and prevention by treatment with N-butyldeoxynojirimycin. J. Biol. Chem. 278: 29496-29501
48. Hahn C, Martin M, Schröder M, Vanier M, Hara Y, Suzuki K, Suzuki K and d'Azzo A (1997) Generalized CNS disease and massive Gm1-ganglioside accumulation in mice defective in lysosomal acid β-galactosidase. Hum. Mol. Genet. 6: 205-211
49. Proia RL (2001) Cloning the beta-hexosaminidase genes. Adv. Genet. 44: 127-135
50. Yamashita T, Wu YP, Sandhoff R, Werth N, Mizukami H, Ellis JM, Dupree JL, Geyer R, Sandhoff K and Proia RL (2005) Interruption of ganglioside synthesis produces central nervous system degeneration and altered axon-glial interactions. Proc. Natl. Acad. Sci. USA 102: 2725-2730
51. Yamashita T, Wada R, Sasaki T, Deng C, Bierfreund U, Sandhoff K and Proia R (1999) A vital role for glycosphingolipid synthesis during development and differentiation. Proc. Natl. Acad. Sci. USA 96: 9142-9147
52. Liu Y, Wada R, Kawai H, Sango K, Deng C, Tai T, McDonald MP, Araujo K, Crawley JN, Bierfreund U, Sandhoff K, Suzuki K and Proia RL (1999) A genetic model of substrate deprivation therapy for a glycosphingolipid storage disorder. J. Clin. Invest. 103: 497-505
53. Craigen WJ (2001) Mouse models of human genetic disorders In The Metabolic & Molecular Bases of Inherited Disease, Scriver C, Beaudet A, Sly W, Valle D (eds) (New York: McGraw-Hill Publishing Co.) pp 379-415
54. Suzuki K, Proia R and Suzuki K (1998) Mouse models of human lysosomal diseases. Brain Pathol. 8: 195-215
55. Elsea SH and Lucas RE (2002) The mousetrap: What we can learn when the mouse model does not mimic the human disease. Ilar. J. 43: 66-79
56. Itoh M, Matsuda J, Suzuki O, Ogura A, Oshima A, Tai T, Suzuki Y and Takashima S (2001) Development of lysosomal storage in mice with targeted disruption of the beta-galactosidase gene: A model of human G(M1)-gangliosidosis. Brain Dev. 23: 379-384
57. Yamanaka S, Johnson MD, Grinberg A, Westhphal H, Crawley JN, Taniike M, Suzuki K and Proia RL (1994) Targeted disruption of the Hexa gene results in mice with biochemical and pathologic features of Tay-Sachs disease. Proc. Natl. Acad. Sci. USA 91: 9975-9979
58. Sango K, Yamanaka S, Hoffmann A, Okuda Y, Grinberg A, Westphal H, McDonald MP, Crawley JN, Sandhoff K, Suzuki K and Proia RL (1995) Mouse models of Tay-Sachs and Sandhoff diseases differ in neurologic phenotype and ganglioside metabolism. Nat. Genet. 11: 170-176
59. Orrenius S, Ankarcrona M and Nicotera P (1996) Mechanisms of calcium-related cell death. Adv. Neurol. 71: 137-149 (discussion 149-151)
60. Back SH, Schroder M, Lee K, Zhang K and Kaufman RJ (2005) ER stress signaling by regulated splicing: IRE1/HAC1/XBP1. Methods 35: 395-416
61. Bonilla M, Nastase KK and Cunningham KW (2002) Essential role of calcineurin in response to endoplasmic reticulum stress. EMBO J. 21: 2343-2353
62. Schroder M and Kaufman RJ (2005) The mammalian unfolded protein response. Annu. Rev. Biochem. 74: 739-789
63. Patil C and Walter P (2001) Intracellular signaling from the endoplasmic reticulum to the nucleus: The unfolded protein response in yeast and mammals. Curr. Opin. Cell Biol. 13: 349-355
64. McCullough KD, Martindale JL, Klotz LO, Aw TY and Holbrook NJ (2001) Gadd153 sensitizes cells to endoplasmic reticulum stress by down-regulating Bcl2 and perturbing the cellular redox state. Mol. Cell. Biol. 21: 1249-1259
65. Wang XZ, Kuroda M, Sok J, Batchvarova N, Kimmel R, Chung P, Zinszner H and Ron D (1998) Identification of novel stress-induced genes downstream of chop. EMBO J. 17: 3619-3630
66. Urano F, Wang X, Bertolotti A, Zhang Y, Chung P, Harding HP and Ron D (2000) Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1. Science 287: 664-666
67. Harding HP, Zhang Y, Bertolotti A, Zeng H and Ron D (2000) Perk is essential for translational regulation and cell survival during the unfolded protein response. Mol. Cell 5: 897-904
68. Nakagawa T, Zhu H, Morishima N, Li E, Xu J, Yankner BA and Yuan J (2000) Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta. Nature 403: 98-103
69. Nakagawa T and Yuan J (2000) Cross-talk between two cysteine protease families. Activation of caspase-12 by calpain in apoptosis. J. Cell Biol. 150: 887-894
70. Yoneda T, Imaizumi K, Oono K, Yui D, Gomi F, Katayama T and Tohyama M (2001) Activation of caspase-12, an endoplastic reticulum (ER) resident caspase, through tumor necrosis factor receptor-associated factor 2-dependent mechanism in response to the ER stress. J. Biol. Chem. 276: 13935-13940
71. Rao RV, Castro-Obregon S, Frankowski H, Schuler M, Stoka V, del Rio G, Bredesen DE and Ellerby HM (2002) Coupling endoplasmic reticulum stress to the cell death program. An Apaf-1-independent intrinsic pathway. J. Biol. Chem. 277: 21836-21842
72. Lei K and Davis RJ (2003) JNK phosphorylation of Bim-related members of the Bcl2 family induces Bax-dependent apoptosis. Proc. Natl. Acad. Sci. USA 100: 2432-2437
73. Jimbo A, Fujita E, Kouroku Y, Ohnishi J, Inohara N, Kuida K, Sakamaki K, Yonehara S and Momoi T (2003) ER stress induces caspase-8 activation, stimulating cytochrome c release and caspase-9 activation. Exp. Cell Res. 283: 156-166
74. Wu G, Lu ZH and Ledeen RW (1995) Induced and spontaneous neuritogenesis are associated with enhanced expression of ganglioside GM1 in the nuclear membrane. J. Neurosci. 15: 3739-3746
75. Brini M, Bano D, Manni S, Rizzuto R and Carafoli E (2000) Effects of PMCA and SERCA pump overexpression on the kinetics of cell Ca(2+) signalling. EMBO J. 19: 4926-4935
76. 2+ release from the endoplasmic reticulum. J. Biol. Chem. 278: 15153-15161
77. Lloyd-Evans E, Pelled D, Riebeling C, Bodennec J, de-Morgan A, Waller H, Schiffmann R and Futerman AH (2003) Glucosylceramide and glucosylsphingosine modulate calcium mobilization from brain microsomes via different mechanisms. J. Biol. Chem. 278: 23594-23599
78. Wang Y, Tsui Z and Yang F (1999) Antagonistic effect of ganglioside GM1 and GM3 on the activity and conformation of sarcoplasmic reticulum Ca(2+)-ATPase. FEBS Lett. 457: 144-148
79. Feng B, Yao PM, Li Y, Devlin CM, Zhang D, Harding HP, Sweeney M, Rong JX, Kuriakose G, Fisher EA, Marks AR, Ron D and Tabas I (2003) The endoplasmic reticulum is the site of cholesterol-induced cytotoxicity in macrophages. Nat. Cell Biol. 5: 781-792
80. 2+ signaling. Curr. Opin. Neurobiol. 8: 398-404
81. Boya P, Cohen I, Zamzami N, Vieira HL and Kroemer G (2002) Endoplasmic reticulum stress-induced cell death requires mitochondrial membrane permeabilization. Cell Death Differ. 9: 465-467
82. Ferri KF and Kroemer G (2001) Organelle-specific initiation of cell death pathways. Nat. Cell Biol. 3: E255-E263
83. Green DR and Kroemer G (2004) The pathophysiology of mitochondrial cell death. Science 305: 626-629
84. Scorrano L, Petronilli V, Di Lisa F and Bernardi P (1999) Commitment to apoptosis by GD3 ganglioside depends on opening of the mitochondrial permeability transition pore. J. Biol. Chem. 274: 22581-22585
85. Hanson CJ, Bootman MD and Roderick HL (2004) Cell signalling: IP3 receptors channel calcium into cell death. Curr. Biol. 14: R933-R935
86. Boehning D, van Rossum DB, Patterson RL and Snyder SH (2005) A peptide inhibitor of cytochrome c/inositol 1,4,5-trisphosphate receptor binding blocks intrinsic and extrinsic cell death pathways. Proc. Natl. Acad. Sci. USA 102: 1466-1471
87. Rippo MR, Malisan F, Ravagnan L, Tomassini B, Condo I, Costantini P, Susin SA, Rufini A, Todaro M, Kroemer G and Testi R (2000) GD3 ganglioside directly targets mitochondria in a bcl-2-controlled fashion. FASEB J. 14: 2047-2054
88. Malisan F, Franchi L, Tomassini B, Ventura N, Condo I, Rippo MR, Rufini A, Liberati L, Nachtigall C, Kniep B and Testi R (2002) Acetylation suppresses the proapoptotic activity of GD3 ganglioside. J. Exp. Med. 196: 1535-1541
89. Wang HJ, Guay G, Pogan L, Sauve R and Nabi IR (2000) Calcium regulates the association between mitochondria and a smooth subdomain of the endoplasmic reticulum. J. Cell Biol. 150: 1489-1498
90. Tomassini B, Malisan F, Franchi L, Nicolo C, Calvo GB, Saito T and Testi R (2004) Calnexin suppresses GD3 synthase-induced apoptosis. FASEB J. 18: 1553-1555
91. Danial NN and Korsmeyer SJ (2004) Cell death: Critical control points. Cell 116: 205-219
92. 2+ concentration of the endoplasmic reticulum is a key determinant of ceramide-induced apoptosis: Significance for the molecular mechanism of Bcl-2 action. EMBO J. 20: 2690-2701
93. 2+ concentration within the endoplasmic reticulum. Proc. Natl. Acad. Sci. USA 97: 5723-5728
94. Oakes SA, Scorrano L, Opferman JT, Bassik MC, Nishino M, Pozzan T and Korsmeyer SJ (2005) Proapoptotic BAX and BAK regulate the type 1 inositol trisphosphate receptor and calcium leak from the endoplasmic reticulum. Proc. Natl. Acad. Sci. USA 102: 105-110
95. Chen R, Valencia I, Zhong F, McColl KS, Roderick HL, Bootman MD, Berridge MJ, Conway SJ, Holmes AB, Mignery GA, Velez P and Distelhorst CW (2004) Bcl-2 functionally interacts with inositol 1,4,5-trisphosphate receptors to regulate calcium release from the ER in response to inositol 1,4,5-trisphosphate. J. Cell Biol. 166: 193-203
96. 2+: A control point for apoptosis. Science 300: 135-139
97. Zong WX, Li C, Hatzivassiliou G, Lindsten T, Yu QC, Yuan J and Thompson CB (2003) Bax and Bak can localize to the endoplasmic reticulum to initiate apoptosis. J. Cell Biol. 162: 59-69